Loading...

WuXi Biologics (Cayman) Inc.

WXIBF•PNK
Healthcare
Biotechnology
$4.70
$0.00(0.00%)
U.S. Market opens in 3h 22m

WuXi Biologics (Cayman) Inc. (WXIBF) Stock Overview

Explore WuXi Biologics (Cayman) Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap19.4B
P/E Ratio26.28
EPS (TTM)$0.17
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$4.64
3 Months$4.88
1 Year Target$5.89

WXIBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of WuXi Biologics (Cayman) Inc. (WXIBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.89.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 26.28 and a market capitalization of 19.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
2.17%
3-Month Change
9.81%
6-Month Change
4.44%
Year-to-Date (YTD) Change
11.37%
1-Year Change
56.67%
3-Year Change
-25.52%
5-Year Change
-67.13%
All-Time (Max) Change
1739.10%

Contact Information

https://www.wuxibiologics.com
+86 510 8183 5000
No. 108, Meiliang Road, Wuxi, NaN, 214092

Company Facts

12,575 Employees
IPO DateJan 30, 2018
CountryCN
Actively Trading

Frequently Asked Questions